New Zealand's slow COVID-19 rollout has reached a milestone six months in the making, with two million doses administered.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
After receiving its first doses in mid-February, vaccinators hit the two million mark on Wednesday.
The first one million doses took more than four months, but the second one million have gone into arms over the last six weeks.
New Zealand's rollout has been designed to rip into life from this month after a long setup phase when only at-risk groups and regional centres have been eligible.
At long last, all seniors aged over 60 have been invited to receive their vaccine.
Accoring to vaccine-tracking news outlet Newsroom, New Zealand is tracking 125th among all nations for vaccine administered for head of population.
New Zealand has approved three vaccines for use - Pfizer, Janssen and AstraZeneca - but is using just Pfizer in its goal to innoculate every consenting adult Kiwi against the virus this year.
Australian Associated Press
